High-quality raw materials and stable production processes are essential to the successful development and manufacture of in vitro diagnostic (IVD) reagents and kits. An assay that performs well during early research must still be converted into a reproducible product with controlled formulations, qualified components, reliable analytical performance, suitable stability, and a scalable manufacturing process.
Creative Enzymes Diagnostic provides integrated contract development and manufacturing support across the IVD product lifecycle. Our services connect assay and formulation development, raw material selection, prototype preparation, analytical evaluation, stability studies, process transfer, filling and kit assembly, OEM manufacturing, and continued supply. Projects can begin with an initial diagnostic concept, an existing RUO method, a prototype formulation, or a commercial product requiring transfer, improvement, or supply-chain support.
Our flexible cooperation model covers individual development tasks as well as coordinated programs from feasibility through pilot and routine production. Depending on project needs, we can supply bulk reagents, semi-finished components, development-stage kits, or finished customer-configured products.
Early development decisions determine whether an assay can achieve the required performance, stability, user workflow, and manufacturing consistency. The following services address distinct reagent and product types while remaining connected through a common development and quality framework.
We develop analyzer-ready clinical chemistry reagent systems for biochemical and turbidimetric testing. Support includes reaction-principle selection, enzyme and raw material screening, R1/R2 formulation, calibration and measuring-range optimization, interference assessment, analyzer adaptation, analytical evaluation, stability studies, and scale-up preparation. This service is suited to new assay concepts as well as existing formulations requiring improved sensitivity, linearity, precision, stability, or instrument compatibility.
For assays in which enzymes provide recognition, analyte conversion, amplification, or reporter activity, we optimize the complete reaction system rather than the enzyme in isolation. Programs may cover direct and coupled-enzyme assays, enzyme-linked immunoassays, molecular diagnostic reactions, or biosensor formats. Enzyme qualification, substrate and cofactor balance, signal-to-noise optimization, prototype configuration, functional stability, and analytical characterization are integrated into one development pathway.
Point-of-care and biosensor products require reagents that remain reliable in small volumes, rapid reaction windows, dry-storage formats, and variable use environments. We formulate reagents for strips, membranes, electrodes, cartridges, microfluidic devices, and portable-reader systems. Development can address whole-sample matrix effects, material compatibility, deposition and drying, rehydration, optical or electrochemical signal response, temperature and humidity tolerance, and prototype-device integration.
We create assay-specific controls and calibrators with concentration levels, matrices, assigned values, and stability profiles designed around their intended use. Services include matrix and analyte selection, formulation, value assignment, traceability planning where suitable reference systems are available, method compatibility or commutability assessment, homogeneity studies, liquid or lyophilized format development, pilot preparation, and manufacturing QC recommendations.
Our IVD technology and manufacturing capabilities cover biochemical assays, ELISA, chemiluminescence, fluorescence immunoassays, time-resolved immunofluorescence, colloidal gold and other membrane-based formats, latex turbidimetry, flow cytometry reagents, and molecular diagnostic systems. The service scope can be configured around a single work package or a coordinated program:
| Service Category | Specific Support |
|---|---|
| Co-development and Process Transfer | Feasibility assessment, prototype refinement, formulation confirmation, process optimization, scale adaptation, analytical method transfer, productivity improvement, and preparation for controlled manufacturing. |
| Customized Formulation and Manufacturing | Liquid reagents such as buffers, substrates, detection components, enzyme solutions, and conjugates; frozen or concentrated formats; and lyophilized reagents designed for improved storage or point-of-care applications. |
| Diagnostic Kit Components | Coated or pre-aliquoted microplates, controls, calibrators, reaction solutions, substrates, wash buffers, extraction reagents, enzyme mixes, and other assay-specific components. |
| Manufacturing Platforms | Biochemical testing, immunoassays, chemiluminescence, fluorescence, colloidal gold and related rapid-test formats, PCR/qPCR/dPCR reagents, reverse-transcription systems, and nucleic acid processing reagents. |
| Quality Control and Stability | Enzyme activity, protein concentration, purity, functional response, batch consistency, control recovery, analytical performance, and accelerated or real-time stability studies according to the agreed product scope. |
| Filling, Assembly, and Product Configuration | Reagent filling, component matching, complete kit assembly, labeling, primary and secondary packaging, customer-approved branding, and batch-level traceability. |
Once an assay formulation has been established, successful commercialization depends on controlled manufacturing, accurate product configuration, effective process transfer, and resilient access to critical raw materials. The following services support the transition from development-stage material to repeatable production and continued supply.
We support build-to-specification OEM manufacture, jointly optimized products, bulk or semi-finished reagent supply, and customer-branded diagnostic kits. Each program begins with technical and manufacturing-readiness review, followed by material qualification, pilot production, process confirmation, branding and configuration approval, batch release, and forecast-based supply planning. Cooperation models can be adapted to established products, portfolio extensions, or assays transitioning from prototype to commercial production.
Qualified bulk reagents can be converted into consistent product configurations through controlled dispensing, closure, component reconciliation, kit assembly, labeling, inspection, and packaging. We support liquid, frozen, concentrated, lyophilized, and dry components in bottles, vials, tubes, plates, cartridges, and other approved formats. Lot-level traceability and finished-kit checks help connect each assembled product to its source materials and production records.
Our transfer support converts development knowledge into processes that can be executed reliably at the receiving site. Services include readiness and gap assessment, identification of critical product and process variables, equipment and scale adaptation, analytical method transfer, engineering batches, process validation planning and execution, personnel training, controlled handover, and continued process verification. Programs can cover R&D-to-manufacturing transfer, site transfer, scale-up, or remediation of an incompletely documented process.
When a diagnostic enzyme, antibody, substrate, excipient, membrane, particle, or packaging component becomes unavailable or inconsistent, replacement must be supported by functional evidence. We assess material criticality, identify and characterize candidates, design matched assay-level equivalency studies, evaluate multiple lots where appropriate, optimize formulation or loading when a direct replacement is not possible, and support stability, pilot manufacturing, change control, and post-implementation monitoring.
Quality controls are selected according to the product's function and development stage. Our analytical capabilities can support enzyme activity, protein concentration, identity or purity evaluation, functional testing, calibration and control response, fill or component consistency, and lot-to-lot comparison. Methods such as SDS-PAGE, Western blotting, HPLC, and assay-specific functional tests can be included when appropriate to the material.
Stability programs can include accelerated, real-time, open-vial, onboard, reconstituted, freeze–thaw, transport, or temperature-excursion conditions. The study design is tailored to the reagent format, container, expected use, and proposed storage claim, providing evidence for formulation optimization and continued shelf-life assessment.
Following small-scale production of a customized diagnostic enzyme, the material was evaluated using SDS-PAGE, Western blotting, and HPLC, together with endotoxin-related testing where required by the project. The combined data were used to assess identity, purity, and suitability of the development batch before further assay or manufacturing work.
Whether your program requires focused reagent development, a complete diagnostic kit, manufacturing transfer, OEM production, or replacement of a critical raw material, Creative Enzymes Diagnostic can establish a service plan around your product stage and technical priorities.
Contact our business development team today to discuss your IVD reagent or diagnostic kit development and manufacturing needs!
